Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Mizuho Securities Raises Price Target on Ironwood Pharma (IRWD) as Milestone Drives 1Q Beat
May 10, 2016 6:43 AM EDTMizuho Securities reiterated a Buy rating on Ironwood Pharmaceuticals (NASDAQ: IRWD), and raised the price target to $16.00 (from $15.00), following the company's 1Q earnings report. IRWD reported $66M in revenues and loss of ($0.08) per share, both ahead of consensus estimates of $53.6M and ($0.14). The beat can be... More
Ironwood Pharma (IRWD) Tops Q1 EPS by 6c
May 9, 2016 4:17 PM EDTIronwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.08), $0.06 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $66 million versus the consensus estimate of $53.58 million.
For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.
... More